A Phase I/II Randomized, Double-Blind, Placebo-Controlle

Project: Research project

Project Details


A Phase I/II Randomized, Double-Blind, Placebo-Controlled,Single-Dose, Dose Escalation Study of KB001 in Cystic FibrosisPatients Infected with Pseudomonas aeruginosa
Effective start/end date11/14/0712/31/09


  • KaloBios Pharmaceuticals, Inc.

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.